Skip to main content
. 2023 Apr 28;23:82. doi: 10.1186/s12935-023-02901-1

Table 2.

Relationship between the SATB2-AS1 expression and HCC patients’ clinical features

Clinical parameters Patients (n) Expression of SATB2-AS1 P-value
High-SATB2-AS1 Low-SATB2-AS1
Total 84 42 42
 Age (years)  < 70 34 15 19 0.374
 ≥ 70 50 27 23
 Gender Male 45 25 20 0.274
Female 39 17 22
 Tumor size (cm)  < 5 24 14 10 0.334
 ≥ 5 60 28 32
 Serum AFP(ng/ml)  < 20 33 15 18 0.503
 ≥ 20 51 27 24
 Cirrhosis of the liver Yes 58 28 30 0.637
No 26 14 12
 TNM stage I-II 34 23 11 0.008*
III-IV 50 19 31
 Tumor recurrence Yes 59 25 34 0.032*
No 25 17 8

*P < 0.05 was statistically significant